Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.
Manolakopoulos
Spilios
S
Department of Gastroenterology, Polyclinic General Hospital, Athens, Greece. spilios1@otenet.gr
Bethanis
Sotirios
S
Armonis
Anastasios
A
Economou
Michalis
M
Avgerinos
Alec
A
Tzourmakliotis
Dimitrios
D
D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D017373:Cyproterone Acetate / Q000009:adverse effects* / Q000627:therapeutic use; D005485:Flutamide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008111:Liver Function Tests; D008297:Male
D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D005485:Flutamide; D001663:Bilirubin